Jakarta, CNBC Indonesia – The pharmaceutical giant Pfizer plans to request an emergency use permit from the US health authorities in November 2020 so that the Covid-19 vaccine it is developing can be used in the US.
Pfizer hopes that vaccine safety data will be available by the third week of November and will immediately apply for emergency use.
“So assuming positive data, Pfizer will apply for an Emergency Authorization Use in the US after security concerns are met in the third week of November,” said Chariman and Pfizer CEO Albert Bourla, as quoted by AFP, Friday (16/10/2020 ).
Pfizer develops the Covid-19 vaccine in collaboration with BioNTech, a German pharmaceutical company. These vaccines contain a material called messenger RNA (mRNA), which is used to train protein cells to make proteins that then fight or prevent targeted disease.
Currently the vaccine is in final phase clinical trials conducted in the US and several European countries. In two previous clinical trials in humans this vaccine has succeeded in creating neutralizing antibodies and stimulating t-cells to fight corona.
The Pfizer vaccine is one of the Covid-19 vaccines that Microsoft founder Bill Gates has championed against corona. The nonprofit Bill & Melinda Gates has donated millions of dollars to Pfizer to develop a vaccine.